🇺🇸 FDA
Patent

US 7998682

Method for assessing atherosclerosis by measuring expression of FOS or DUSP1 in monocytes

granted A61PA61P9/10

Quick answer

US patent 7998682 (Method for assessing atherosclerosis by measuring expression of FOS or DUSP1 in monocytes) held by The United States of America as Represented by the Secretary of the Department of Health and Human Services expires Mon Aug 11 2031 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America as Represented by the Secretary of the Department of Health and Human Services
Grant date
Tue Aug 16 2011 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Aug 11 2031 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
30
CPC classes
A61P, A61P9/10